News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,466 Results
Type
Article (14819)
Company Profile (298)
Press Release (265344)
Multimedia
Podcasts (73)
Webinars (11)
Section
Business (79794)
Career Advice (159)
Deals (13321)
Drug Delivery (38)
Drug Development (50670)
Employer Resources (31)
FDA (5824)
Job Trends (5163)
News (145001)
Policy (10067)
Tag
Academia (918)
Accelerated approval (18)
Adcomms (14)
Allergies (79)
Alliances (21762)
ALS (123)
Alzheimer's disease (1020)
Antibody-drug conjugate (ADC) (223)
Approvals (6005)
Artificial intelligence (244)
Autoimmune disease (100)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (98)
Biotechnology (229)
Bladder cancer (96)
Brain cancer (43)
Breast cancer (325)
Cancer (2986)
Cardiovascular disease (229)
Career advice (145)
Career pathing (6)
CAR-T (213)
CDC (5)
Cell therapy (547)
Cervical cancer (14)
Clinical research (43476)
Collaboration (1067)
Company closure (2)
Compensation (555)
Complete response letters (36)
COVID-19 (1094)
CRISPR (82)
C-suite (505)
Cystic fibrosis (109)
Data (4152)
Denatured (13)
Depression (83)
Diabetes (248)
Diagnostics (1371)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (178)
Drug pricing (44)
Drug shortages (3)
Duchenne muscular dystrophy (204)
Earnings (31553)
Editorial (23)
Employer branding (4)
Employer resources (29)
Events (51468)
Executive appointments (612)
FDA (7462)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (22)
Funding (939)
Gene editing (170)
Generative AI (19)
Gene therapy (466)
GLP-1 (489)
Government (1140)
Grass and pollen (3)
Guidances (162)
Healthcare (6607)
HIV (16)
Huntington's disease (41)
IgA nephropathy (73)
Immunology and inflammation (181)
Immuno-oncology (28)
Indications (51)
Infectious disease (1196)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (36)
Intellectual property (155)
Interviews (18)
IPO (7333)
IRA (12)
Job creations (867)
Job search strategy (129)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (40)
Longevity (9)
Lung cancer (408)
Lymphoma (241)
Machine learning (23)
Management (7)
Manufacturing (349)
MASH (129)
Medical device (2658)
Medtech (2665)
Mergers & acquisitions (6573)
Metabolic disorders (694)
Multiple sclerosis (95)
NASH (13)
Neurodegenerative disease (212)
Neuropsychiatric disorders (65)
Neuroscience (1891)
NextGen: Class of 2026 (2032)
Non-profit (864)
Now hiring (28)
Obesity (311)
Opinion (122)
Ovarian cancer (125)
Pain (92)
Pancreatic cancer (150)
Parkinson's disease (217)
Partnered (12)
Patents (283)
Patient recruitment (299)
Peanut (43)
People (26547)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase I (15401)
Phase II (20197)
Phase III (12769)
Pipeline (2782)
Policy (87)
Postmarket research (853)
Preclinical (6521)
Press Release (30)
Prostate cancer (139)
Psychedelics (48)
Radiopharmaceuticals (232)
Rare diseases (589)
Real estate (1446)
Recruiting (12)
Regulatory (9742)
Reports (19)
Research institute (968)
Resumes & cover letters (18)
Rett syndrome (22)
RNA editing (17)
RSV (16)
Schizophrenia (120)
Series A (176)
Series B (126)
Service/supplier (1)
Sickle cell disease (75)
Special edition (18)
Spinal muscular atrophy (118)
Sponsored (15)
Startups (2002)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (17)
The Weekly (59)
Vaccines (322)
Venture capital (62)
Weight loss (166)
Women's health (24)
Worklife (2)
Date
Today (1)
Last 7 days (520)
Last 30 days (1120)
Last 365 days (18057)
2026 (536)
2025 (18096)
2024 (20545)
2023 (22414)
2022 (26823)
2021 (27805)
2020 (23357)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11840)
2015 (14350)
2014 (10394)
2013 (7486)
2012 (7535)
2011 (7615)
2010 (7428)
Location
Africa (153)
Alabama (63)
Alaska (2)
Arizona (67)
Arkansas (5)
Asia (18168)
Australia (3088)
California (6810)
Canada (1785)
China (727)
Colorado (233)
Connecticut (240)
Delaware (226)
Europe (39002)
Florida (856)
Georgia (203)
Hawaii (2)
Idaho (17)
Illinois (376)
India (31)
Indiana (153)
Iowa (8)
Japan (207)
Kansas (79)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (716)
Massachusetts (5399)
Michigan (104)
Minnesota (239)
Mississippi (3)
Missouri (31)
Montana (16)
Nebraska (5)
Nevada (30)
New Hampshire (18)
New Jersey (1590)
New Mexico (13)
New York (1698)
North Carolina (799)
North Dakota (6)
Northern California (3323)
Ohio (175)
Oklahoma (11)
Oregon (24)
Pennsylvania (1229)
Puerto Rico (8)
Rhode Island (25)
South America (210)
South Carolina (9)
Southern California (2691)
Tennessee (38)
Texas (880)
United States (22504)
Utah (93)
Virginia (131)
Washington D.C. (36)
Washington State (567)
West Virginia (1)
Wisconsin (40)
280,466 Results for "interline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
Yield10 Bioscience, Inc. today announced that UPL Ltd. (“UPL”) has received U.S. Environmental Protection Agency (“EPA”) approval to amend the label language of INTERLINE ® Herbicide to include the oilseed Camelina sativa (“Camelina”).
May 23, 2024
·
4 min read
Press Releases
Force Therapeutics Celebrates 2025 Research Impact
January 9, 2026
·
2 min read
Press Releases
Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment
January 9, 2026
·
4 min read
Biotech Bay
Interline Therapeutics Launches With $92 Million to Map and Correct Dysfunctional Protein Communities
Interline Therapeutics, a Foresite Labs incubated company focused on systematically elucidating protein communities to define molecular mechanisms of disease, announced today that the company has raised $92 million.
May 13, 2021
·
5 min read
Press Releases
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 23, 2025
·
6 min read
Press Releases
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
·
4 min read
Press Releases
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
January 8, 2026
·
3 min read
Press Releases
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
January 6, 2026
·
5 min read
Drug Development
Interline Will Focus $92 Million Investment to Advance Precision Medicine Platform
Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.
May 14, 2021
·
2 min read
·
Brandon May
Press Releases
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
January 8, 2026
·
11 min read
1 of 28,047
Next
